Lakewood-Amedex Biotherapeutics Inc. Common Stock Share Price
NASDAQ: LABT
Live Lakewood-Amedex Biotherapeutics Inc. Common Stock Share Price Chart
O H L
Lakewood-Amedex Biotherapeutics Inc. Common Stock Performance Overview
Days Range
▼
$1.93Low
$1.99High
Markets Today
| Previous Close | $1.86 |
|---|---|
| Open | $1.93 |
| Volume | 118,574 |
| Day's Range | $1.93 - $1.99 |
| 52W Range | NA |
| Market Cap | $4.95 M |
Historical Performance
| 1M Returns | -19.13 |
|---|---|
| 3M Returns | -51.83 |
| 6M Returns | NA |
| 1Y Returns | NA |
| 5Y Returns | NA |
| 10Y Returns | NA |
Lakewood-Amedex Biotherapeutics Inc. Common Stock Fundamentals
| Market Cap | $4.95 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
| Market Cap | $4.95 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
Lakewood-Amedex Biotherapeutics Inc. Common Stock Profit & Loss
Quarterly
| Jun 2026 | |
|---|---|
| Total Revenue + | $0 |
| Gross Profit + | $0 |
| Operating Income | -$3.79 M |
| EBITDA | -$3.79 M |
| Interest Expense | -$10.63 K |
| Depreciation | $1.16 K |
| Income Before Tax | -$3.77 M |
| Income Tax Expense | $0 |
| Net Income + | -$3.77 M |
| Net Profit Margin | - |
Lakewood-Amedex Biotherapeutics Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Jun 2026 | |
|---|---|
| Share Capital | $217 |
| Reserve & Surplus | -$68.64 M |
| Non-Current Liabilities | $0 |
| Current Liabilities | $628.93 K |
| Total Liabilities | $628.93 K |
| Fixed Assets | $6.91 K |
| Current Assets | $4.85 M |
| Total Assets | $4.96 M |
Lakewood-Amedex Biotherapeutics Inc. Common Stock Cash Flow
Quarterly
| Jun 2026 | |
|---|---|
| Net Income | -$3.77 M |
| Operating Cash Flow | -$2.10 M |
| Investing Cash Flow | -$2.00 M |
| Financing Cash Flow | $6.68 M |
| Change in Cash | $2.57 M |
Lakewood-Amedex Biotherapeutics Inc. Common Stock Return Calculator
The Lakewood-Amedex Biotherapeutics Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Lakewood-Amedex Biotherapeutics Inc. Common Stock
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
Popular Stocks
FAQs
What is the share price of Lakewood-Amedex Biotherapeutics Inc. Common Stock today?
Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) share price as of September 18, 2026 is $1.92. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Lakewood-Amedex Biotherapeutics Inc. Common Stock?
Yes, Indian Investors can invest in the Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) Share by opening an international trading account with Angel One.
How can I purchase Lakewood-Amedex Biotherapeutics Inc. Common Stock shares in India?
Purchasing Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Lakewood-Amedex Biotherapeutics Inc. Common Stock?
Yes, you can purchase fractional shares of Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Lakewood-Amedex Biotherapeutics Inc. Common Stock?
The market capitalization of Lakewood-Amedex Biotherapeutics Inc. Common Stock on September 18, 2026, is $4.95 M.
In which sector Lakewood-Amedex Biotherapeutics Inc. Common Stock belongs?
Lakewood-Amedex Biotherapeutics Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in Lakewood-Amedex Biotherapeutics Inc. Common Stock stocks?
In order to invest in Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
